A Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis

Clinical trial NCT07406035 · RECRUITING

Trial details

NCT number: NCT07406035
Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Psoriatic Arthritis

Start date: 2026-07-16
Primary completion: 2027-08-01
Enrollment: 156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.